ULTIMED ANNOUNCES DEVELOPMENT OF ULTIGUARD FOR PEN NEEDLES

ST. PAUL, MINNESOTA – August 11, 2005 – UltiMed has launched the design phase for UltiGuard pen needles. Like UltiGuard syringes, UltiGuard pen needles will be sold in a dual-use container which is a dispenser as well as a sharps container. The design phase will include input from diabetic educators, pen needle users and experts in industrial design, injection molding, automated packaging and manufacturing.

Tom Erickson, UltiMed’s CEO said, “Pen injection for insulin has surpassed injection with syringes in Europe, Japan and Canada. The use of pen injection is predicted to increase dramatically in the U.S. Because accidental pen needle sticks and the safe disposal of used pen needles has turned into a major social issue, UltiMed must accelerate the development and market introduction of UltiGuard and private label UltiGuard pen needles.”

UltiMed, Inc. which is headquartered in St. Paul, Minnesota markets syringes, needles, pen needles, lancets and innovative dual-purpose sharps containers for both the domestic and international markets. The Company owns and operates state of the art medical device manufacturing facilities in the U.S. and abroad. UltiMed also has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world.

UltiMed Inc., 287 East 6th Street, St. Paul, MN 55101 www.ulti-care.com